Log In
    TZOO
    $19.14
    (-2.4%)
    FLWS
    $7.39
    (3.21%)
    ACCO
    $4.99
    (-0.6%)
    AUXXF
    $0.1
    (-0.92%)
    ARLP
    $27.48
    (1.07%)
    ALVOF
    $3.65
    (0.55%)
    AUIAF
    $0.27
    (9.76%)
    BSET
    $13.85
    (0%)
    BXRX
    $0
    (0%)
    BBGI
    $8.64
    (-9.91%)
    BSGM
    $1.41
    (-2.08%)
    BLBX
    $1.86
    (-1.59%)
    LUCK
    $10.25
    (-1.54%)
    COCP
    $2.08
    (-6.05%)
    CDRO
    $6.11
    (-3.34%)
    LODE
    $0.28
    (-46.77%)
    CMTL
    $2.34
    (-43.34%)
    CXW
    $22.09
    (0.05%)
    LCE:CA
    $0.29
    (-3.33%)
    CMLS
    $0.79
    (2.32%)
    DEFN:CA
    $0.18
    (-12.2%)
    DTGI
    $0.01
    (0%)
    DRCT
    $1.62
    (-1.22%)
    DLHC
    $7.66
    (2.54%)
    SSP
    $2.29
    (-2.97%)
    EGLE
    $62.6
    (0%)
    ELMGF
    $0.03
    (20.44%)
    UUUU
    $5.24
    (-0.76%)
    GAME
    $0.89
    (0%)
    EVC
    $2.4
    (-10.11%)
    ESK:CA
    $0.17
    (0%)
    GMBL
    $0.22
    (-11.8%)
    EDRY
    $11.45
    (4.85%)
    ESEA
    $34.46
    (-1.77%)
    GNK
    $14.58
    (0.62%)
    GEVO
    $2.15
    (-4.87%)
    GRIN
    $14.2
    (0%)
    GTN
    $3.27
    (-3.54%)
    HHS
    $5.13
    (-1.35%)
    INDO
    $3.26
    (0.31%)
    IPOOF
    $1.25
    (0%)
    KNDI
    $1
    (-1.96%)
    MSGM
    $1.29
    (-3.73%)
    PANL
    $5.56
    (2.39%)
    PXS
    $4.04
    (-1.82%)
    QMCI
    $0.14
    (6.77%)
    SALM
    $0.6
    (-11.76%)
    SHIP
    $7.09
    (-1.94%)
    TSQ
    $9.03
    (1.69%)
    TZOO
    $19.14
    (-2.4%)
    FLWS
    $7.39
    (3.21%)

    channelchek-in

    ‌
    1/13/2025

    Biotech Merger: Salarius and Decoy Unite to Advance AI-Driven Peptide Therapeutics

    In a strategic move to accelerate the development of next-generation therapeutics, Salarius Pharmaceuticals (NASDAQ: SLRX) announced today its merger with privately-held Decoy Therapeutics in an all-stock transaction. The combined company, which will operate under the Decoy Therapeutics name, aims to leverage artificial intelligence and machine learning to revolutionize peptide conjugate drug development.

    0
    2 min read
    • ‌
      Noble Capital Markets Research Morning Call

      Noble Capital Markets Research Morning Call

      Today’s Noble Capital Markets equity research reports, available with free...

      115 min read

    • Clearwater’s Enfusion Acquisition Bridges Front-to-Back Office Gap

      3 min read

    • Receive FREE Research, News, Video, and Event Updates in Your Inbox!

    • California Inferno Impact: Insurance Stocks Plunge as LA Wildfires Cause $20B in Expected Losses

      3 min read
    View all

    News

    1/13/2025

    Release – Kratos Receives New Hypersonic System Program Award with Total Potential Value of Approximately $100 Million

    5 min read
    ‌
    Release – Kratos Receives New Hypersonic System Program Award with Total Potential Value of Approximately $100 Million
    1/13/2025

    Release – V2X Names L. Roger Mason to Chief Growth Officer

    3 min read
    ‌
    Release – V2X Names L. Roger Mason to Chief Growth Officer
    1/13/2025

    Release – Comtech Announces Financial Results for the First Quarter of Fiscal 2025

    13 min read
    ‌
    Release – Comtech Announces Financial Results for the First Quarter of Fiscal 2025
    1/13/2025

    Release – Comtech Announces CEO Transition and Comprehensive Transformation Initiatives

    6 min read
    ‌
    Release – Comtech Announces CEO Transition and Comprehensive Transformation Initiatives
    View all

    Research Reports

    FAT Brands (FAT) – More Details on Twin Hospitality DistributionB(Aurania Resources (AUIAF) – Priorities for 2025AR(Bitcoin Depot (BTM) – Scores Another Retail PartnershipBD(Kratos Defense & Security (KTOS) – Award Momentum ContinuesKDS
    View all

    Video Content

  • ‌
    P3 Health Partners

    P3 Health Partners

    Conference Presentation
    12/19/2024
  • ‌
    Unicycive Therapeutics Inc.

    Unicycive Therapeutics Inc.

    Conference Presentation
    12/19/2024
  • ‌
    Performant

    Performant

    Conference Presentation
    12/18/2024
  • ‌
    BioHarvest Sciences

    BioHarvest Sciences

    Conference Presentation
    12/17/2024
    • View all

    Movers

    Symbol
    Change
    PHIO
    290.53%
    SLRX
    134.5%
    VRME
    61.96%
    ATPC
    56.35%
    MTEM
    46.77%
    View all
    Log In